CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive strategic advisor to The Acrobot Company Limited in the sale to Stanmore Implants Worldwide Ltd. Financial terms were not disclosed.
The Acrobot Company Limited (London, United Kingdom) provides precision surgical systems for computer-assisted 3D planning, surgical navigation and surgeon-controlled robotic surgery. Acrobot’s technologies is to provide speed, accuracy and reproducibility, enhancing clinical outcomes, whilst augmenting surgeon skills and facilitating bone conservation and increasing productivity. Acrobot’s founders include Brian Davies, Professor of Medical Robotics in the Department of Mechanical Engineering at Imperial College and Justin Cobb, Professor of Orthopaedics at Imperial College and a practising surgeon at Charing Cross Hospital, London. For more information, visit www.acrobot.co.uk
Stanmore Implants Worldwide Limited (Stanmore, United Kingdom) is an innovative orthopaedic business focused on design and manufacture of bespoke implants for limb sparing and complex primary and revision joint replacement. Stanmore designs, manufactures and markets a custom implant service and is known for creating some of the world’s most successful implants. For more information, visit www.stanmoreimplants.com
CATALYSIS Advises Life Science Innovators. Based in London, United Kingdom, CATALYSIS CAPITAL PARTNERS provides financial and strategic advice to industry leaders and emerging growth companies in diagnostics, medical devices, biotechnology and drug delivery. CATALYSIS brings a unique combination of broad transactional experience, extensive industry expertise and senior-level focus to each client relationship. CATALYSIS CAPITAL PARTNERS is authorized and regulated by the Financial Conduct Authority (FCA) UK.